Tavneos
Payments companies reported to CMS as associated with Tavneos. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tavneos, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tavneos
These are the largest totals companies reported as associated with Tavneos. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Luis Alvarez | Palo Alto, CA | Nephrology (Internal Medicine) | $315,617.44 |
| Adam Kilian | Saint Louis, MO | Rheumatology | $202,866.85 |
| Reza Zonozi | Fairfax, VA | Nephrology (Internal Medicine) | $180,950.23 |
| Frank Cortazar | Albany, NY | Nephrology (Internal Medicine) | $171,978.02 |
| Lindsay Lally | New York, NY | $162,373.88 | |
| Dhiman Basu | Colleyville, TX | Rheumatology | $137,654.45 |
| David Bulbin | Danville, PA | Rheumatology | $109,543.71 |
| Adam Brown | Cleveland, OH | Rheumatology | $106,125.22 |
| Christopher Parker | West Lake Hills, TX | Rheumatology | $104,777.89 |
| Bryan Gescuk | San Mateo, CA | Rheumatology | $101,247.14 |
Prescribed Tavneos?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.